Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
Recruiting
N/A
Interventional Study
Hearing Loss, Sensorineural
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 10 (estimated)
- Sponsor
- Pamukkale University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with sensorineural hearing loss
* Patients who will have cochlear implant surgery with CI422 electrode
Exclusion Criteria:
* Patients with cochlear abnormality
* Patients with auditory neuropathy
Contacts